Status
Conditions
Treatments
About
This study will evaluate the effectiveness and benefit of treatment with onabotulinumtoxinA in Chronic Migraine patients who have received a minimum of 7 treatment cycles.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
33 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal